Global Pet Noise Anxiety Market By Pet Type (Dogs, Cats and Other Pets), By Product Type (Medications, Nutraceuticals and Supplements, Calming Wraps and Vests, Pheromone Products and Others), By Distribution Channel (Veterinary Hospitals, Retail Pharmacies, Online Pharmacies, Pet Specialty Stores and Others), By End User (Pet Owners, Veterinary Hospitals, Animal Shelters and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2026-2035

Report Overview

The Global Pet Noise Anxiety Market size is expected to be worth around US$ 2.8 Billion by 2035 from US$ 1.5 Billion in 2025, growing at a CAGR of 6.5% during the forecast period 2026-2035. In 2025, North America led the market, achieving over 39.4% share with a revenue of US$ 0.6 Billion.

Increasing awareness of pet behavioral health and the emotional well-being of companion animals drives the Pet Noise Anxiety market as pet owners and veterinarians seek effective, non-invasive solutions to manage stress-related behaviors triggered by loud sounds.

Pet owners increasingly turn to pheromone-based products such as ADAPTIL diffusers and sprays to create a calming environment during thunderstorms, fireworks, or construction noise, helping dogs maintain normal behavior and reduce symptoms like pacing, hiding, or destructive actions.

These solutions support noise desensitization programs by providing consistent calming signals that complement behavioral training, enabling gradual exposure to recorded sounds without overwhelming the animal.

Veterinarians apply pheromone therapies as adjunctive support in anxiety management plans for dogs with separation anxiety or generalized noise phobias, improving compliance with behavior modification exercises and reducing reliance on sedative medications.

The market also addresses feline noise sensitivity, where calming diffusers help cats cope with household sounds or travel-related stress, minimizing hiding, vocalization, or inappropriate elimination. In multi-pet households, these products create a more harmonious environment by reducing stress-induced conflicts during loud events.

Manufacturers pursue opportunities to expand pheromone-based and nutraceutical formulations that combine calming agents with natural ingredients, broadening applications in preventive wellness programs for noise-sensitive breeds or pets with known anxiety histories.

These advancements support integration with wearable calming devices and smart home systems that activate calming signals in response to detected loud sounds, offering automated support for working pet parents.

In February 2026, Ceva Santé Animale relocated its Asia-Pacific headquarters to Shanghai as part of a regional expansion strategy. Alongside leadership restructuring, including the appointment of a dedicated head for pet products, the company aims to strengthen its presence in the fast-growing Asia-Pacific pet behavioral segment.

Its ADAPTIL pheromone-based product range is expected to benefit from rising pet ownership and increasing demand for non-pharmaceutical behavioral solutions across the region.

Recent trends emphasize multimodal approaches that combine environmental management, behavioral training, and pheromone or supplement support, positioning the Pet Noise Anxiety market for growth in holistic, science-backed solutions that improve quality of life for both pets and their owners.

Key Takeaways

• In 2025, the market generated a revenue of US$ 1.5 Billion, with a CAGR of 6.5%, and is expected to reach US$ 2.8 Billion by the year 2035.
• The pet type segment is divided into dogs, cats and other pets, with dogs taking the lead with a market share of 72.8%.
• Considering product type, the market is divided into medications, nutraceuticals and supplements, calming wraps and vests, pheromone products and others. Among these, medications held a significant share of 35.1%.
• Furthermore, concerning the distribution channel segment, the market is segregated into veterinary hospitals, retail pharmacies, online pharmacies, pet specialty stores and others. The veterinary hospitals sector stands out as the dominant player, holding the largest revenue share of 42.6% in the market.
• The end user segment is segregated into pet owners, veterinary hospitals, animal shelters and others, with the pet owners segment leading the market, holding a revenue share of 34.6%.
• North America led the market by securing a market share of 39.4%..

Pet Type Analysis

Dogs accounted for 72.8% of growth within pet type and dominate the pet noise anxiety market due to their higher sensitivity to loud sounds such as fireworks, thunderstorms, and urban noise. Behavioral studies indicate that a significant portion of dogs exhibit fear responses to sudden or repetitive noise stimuli, which increases demand for anxiety management solutions.

Pet owners frequently observe visible symptoms such as trembling, excessive barking, and destructive behavior, which drives early intervention. Dogs are expected to remain the leading segment as global dog ownership continues to rise.

Owners are likely to invest in products and therapies that improve pet comfort and reduce stress-related health issues. The segment benefits from strong emotional bonding between owners and dogs, which encourages spending on behavioral care.

Increasing awareness of animal mental health is projected to support product adoption. As behavioral management becomes a key focus in pet care, dogs are estimated to maintain their dominant position in this market.

Product Type Analysis

Medications accounted for 35.1% of growth within product type and dominate the pet noise anxiety market due to their effectiveness in managing moderate to severe anxiety symptoms. Veterinarians prescribe anti-anxiety drugs and sedatives to provide immediate relief during high-stress situations such as fireworks or travel.

Clinical observations show that pharmacological interventions are often necessary when behavioral methods alone do not provide sufficient control. Medications are expected to expand as awareness of veterinary behavioral health increases.

Pet owners are likely to prefer medically supervised solutions for severe anxiety cases. The segment benefits from rapid onset of action and measurable symptom reduction.

Increasing availability of safer and more targeted formulations is projected to support growth. As demand for effective anxiety management rises, medications are anticipated to remain the leading product segment in this market.

Distribution Channel Analysis

Veterinary hospitals accounted for 42.6% of growth within distribution channel and dominate the pet noise anxiety market due to their role in diagnosis, prescription, and treatment planning. Pet owners rely on veterinarians to assess anxiety severity and recommend appropriate solutions.

Veterinary hospitals are expected to remain dominant as many anxiety treatments require professional consultation and monitoring. The segment benefits from growing pet healthcare spending and increasing trust in veterinary expertise.

Hospitals are likely to provide both pharmacological and behavioral therapy options, which strengthens their position. Rising awareness of animal mental health is projected to support clinic visits for anxiety-related issues. As veterinary care continues to expand, this distribution channel is estimated to aamaintain its leading position in the market.

End-User Analysis

Pet owners accounted for 34.6% of growth within end user and dominate the pet noise anxiety market due to their direct responsibility for managing pet behavior and well-being. Owners actively seek solutions to reduce anxiety symptoms and improve pet quality of life.

Increasing pet humanization trends drive higher spending on behavioral care products and services. Pet owners are expected to remain the primary end users as awareness of pet anxiety continues to grow. They are likely to adopt a combination of products, including medications, supplements, and calming devices.

The segment benefits from easy access to products through multiple distribution channels. As emotional bonding with pets strengthens, pet owners are estimated to maintain their dominant share in this market.

Key Market Segments

By Pet Type

• Dogs
• Cats
• Other Pets

By Product Type

• Medications
• Nutraceuticals and Supplements
• Calming Wraps and Vests
• Pheromone Products
• Others

By Distribution Channel

• Veterinary Hospitals
• Retail Pharmacies
• Online Pharmacies
• Pet Specialty Stores
• Others

By End User

• Pet Owners
• Veterinary Hospitals
• Animal Shelters
• Others

Drivers

Rising pet ownership combined with heightened sensitivity to environmental noises is driving the Pet Noise Anxiety market.

The substantial growth in companion animal populations has amplified the incidence of stress responses triggered by loud sounds such as fireworks, thunderstorms, and urban disturbances. Surveys indicate that a significant proportion of dogs exhibit fear reactions to fireworks and thunder, contributing to consistent demand for calming interventions.

Pet owners increasingly view animals as family members and prioritize solutions that mitigate distress during predictable noise events. This humanization trend encourages proactive purchases of medications, wraps, and environmental aids rather than reactive measures alone.

Veterinary recommendations for noise aversion management further integrate these products into routine care protocols. Urban living exposes pets to frequent auditory stimuli, elevating baseline anxiety levels across canine and feline populations.

Seasonal peaks around holidays and weather events sustain year-round market interest through anticipatory buying patterns. Enhanced awareness campaigns by animal welfare organizations reinforce the clinical importance of addressing noise-related behaviors.

The availability of diverse non-invasive options broadens accessibility for various household budgets and preferences. Consequently, demographic expansion and evolving owner expectations establish a core impetus for sustained market development during the 2022–2025 period.

Restraints

Variable efficacy of existing interventions and owner skepticism are restraining the Pet Noise Anxiety market.

Many available calming products demonstrate inconsistent results across individual animals, leading some owners to question their reliability and hesitate on repeat purchases. Behavioral therapies require time and consistency that busy households may find difficult to maintain, resulting in partial adherence and suboptimal outcomes.

High costs associated with prescription medications or specialized garments limit uptake among price-sensitive segments despite recognized needs. Limited large-scale clinical data on certain over-the-counter solutions fosters caution among veterinary professionals when recommending specific items.

Regional differences in product availability and regulatory oversight create uneven market penetration. Some pet owners prefer traditional environmental modifications over commercial offerings, perceiving them as sufficient or more natural. These perceptual and practical barriers slow the transition toward comprehensive management strategies.

Persistent gaps in standardized efficacy metrics further complicate informed decision-making at the point of sale. As a result, such challenges impose a moderating influence on broader adoption rates throughout the 2022–2025 timeframe.

Opportunities

Development of non-pharmacological and technology-enabled calming solutions is creating growth opportunities in the Pet Noise Anxiety market.

Innovative wearables, pheromone diffusers, and pressure garments offer drug-free alternatives that appeal to owners seeking minimal intervention approaches. Opportunities arise for integration with smart home systems that detect noise events and automatically deploy calming stimuli such as white noise or soothing scents.

Expansion into subscription models for replenishable supplements or app-connected monitoring devices supports recurring engagement and data-driven adjustments. Customization features tailored to breed-specific sensitivities or individual histories enhance perceived value and effectiveness.

Collaboration between product developers and behavioral specialists facilitates evidence-based refinements that strengthen consumer confidence. Potential exists for bundled packages combining multiple modalities for comprehensive noise event preparedness.

These advancements align with preferences for holistic pet wellness and facilitate entry into new demographic segments. Scalable manufacturing and e-commerce distribution channels lower entry barriers while expanding geographic reach.

Overall, technological and formulation innovations unlock substantial avenues for differentiation and extended market participation across diverse care settings.

Impact of Macroeconomic / Geopolitical Factors

Macroeconomic realities and geopolitical developments are shaping both consumption behavior and supply-side stability in the pet noise anxiety market in a distinctly layered manner. Growth remains anchored in rising pet adoption and the shift toward treating animals as family members, which continues to elevate spending on behavioral health solutions and anxiety-relief products.

At the same time, inflation is increasing the cost of supplements, medications, and wearable calming products, which is forcing pet owners to become more selective, particularly in non-essential or premium categories.

Trade disruptions and currency instability are affecting the sourcing of ingredients, packaging materials, and electronic components used in advanced calming devices, creating cost variability for manufacturers.

Geopolitical tensions are also influencing regulatory clarity around emerging solutions such as cannabinoid-based products, which impacts product development and commercialization timelines.

Current US tariffs on selected imported inputs, including electronic components and chemical intermediates, are raising production and distribution costs across the value chain. These cost pressures can slow adoption in price-sensitive markets and limit accessibility for first-time users.

However, market participants are actively responding through localized manufacturing, diversified sourcing strategies, and increased focus on affordable over-the-counter solutions.

In a broader view, despite short-term economic and trade-related headwinds, sustained pet humanization and growing awareness of animal mental health are expected to maintain a stable and progressively expanding market outlook.

Latest Trends

Increased adoption of wearable calming devices and digital monitoring tools represents a recent trend in the Pet Noise Anxiety market.

In 2024 and 2025, manufacturers have introduced advanced wearables equipped with sensors that monitor physiological indicators of stress and deliver targeted interventions such as gentle pressure or vibrational cues. This progression enables real-time response to noise triggers without constant owner supervision, improving practicality during unpredictable events.

Integration with mobile applications allows tracking of anxiety patterns and sharing of insights with veterinary professionals for personalized adjustments. Industry observations during this period highlight growing consumer preference for non-invasive, reusable solutions amid heightened focus on pet mental well-being.

Seasonal promotions tied to fireworks and storm seasons have accelerated trial and adoption of these technologies. The trend reflects a broader shift toward preventive, data-informed strategies that complement or reduce reliance on traditional medications.

Continued refinement of user-friendly designs has supported wider implementation in both urban and suburban households. Prominent developments observed in 2024–2025 underscore an evolution toward intelligent, responsive tools that prioritize welfare and convenience in managing noise aversion.

Regional Analysis

North America is leading the Pet Noise Anxiety Market

North America accounted for 39.4% of the pet noise anxiety market in 2025, reflecting heightened awareness of behavioral health issues in companion animals and increased spending on preventive care solutions. Pet owners across the United States are actively seeking products and therapies to manage stress responses triggered by fireworks, thunderstorms, and urban noise exposure.

Evidence from the American Veterinary Medical Association indicates that a significant proportion of dogs exhibit anxiety-related behaviors, with noise sensitivity recognized as a common concern in clinical practice.

Veterinary professionals are incorporating behavioral assessments into routine consultations and recommending a combination of pharmacological and non-pharmacological interventions. Demand has expanded for calming supplements, pheromone-based products, pressure garments, and prescription medications designed to reduce anxiety symptoms.

Growth in pet humanization trends has encouraged owners to prioritize emotional well-being alongside physical health. Digital platforms and wearable technologies are also emerging to monitor stress indicators and guide intervention strategies.

Product innovation focusing on natural ingredients and long-lasting effects has strengthened consumer adoption. These dynamics have collectively supported steady expansion of behavioral health solutions for companion animals across North America in 2025.

The Asia Pacific region is expected to experience the highest CAGR during the forecast period

Asia Pacific is expected to demonstrate notable growth over the forecast period as urban lifestyles and rising pet ownership increase focus on animal behavior management. Countries such as China, Japan, South Korea, and Australia are witnessing a shift toward companion animals being treated as family members, which is influencing spending patterns on wellness products.

The World Organisation for Animal Health emphasizes the importance of behavioral welfare in maintaining overall animal health, encouraging adoption of preventive care practices. Veterinary clinics in the region are gradually integrating behavioral consultations and recommending targeted solutions for stress-related conditions.

Increasing exposure to high-density urban environments is contributing to higher incidence of noise-related stress among pets. Manufacturers are introducing region-specific calming products that align with consumer preferences and cultural factors. E-commerce platforms are improving product accessibility and awareness among pet owners.

Training initiatives are enhancing veterinarian knowledge in behavioral health and anxiety management. These developments are expected to support sustained growth of pet behavioral care solutions across Asia Pacific.

Key Regions and Countries

North America

• The US
• Canada

Europe

• Germany
• France
• The U.K.
• Italy
• Spain
• Russia & CIS
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• ASEAN
• Australia & New Zealand
• Rest of Asia Pacific

Middle East & Africa

• GCC
• South Africa
• Rest of Middle East & Africa

Latin America

• Brazil
• Mexico
• Rest of Latin America

Key Players Analysis

Key participants in the Pet Noise Anxiety Market expand growth by developing behavior-focused calming solutions, strengthening partnerships with veterinarians and pet trainers, and introducing multi-modal products that address anxiety triggered by fireworks, thunderstorms, and travel.

Companies invest in pheromone diffusers, nutraceutical supplements, and wearable calming devices that help reduce stress responses in companion animals. They also expand e-commerce channels and educational campaigns that guide pet owners on preventive care and anxiety management techniques.

Ceva Santé Animale represents a prominent participant in the Pet Noise Anxiety Market and operates as a France-based animal health company that develops behavior-modifying products, pharmaceuticals, and pet care solutions for global markets.

The company emphasizes innovation in pheromone-based calming technologies and veterinary collaboration to improve animal well-being. Industry competitors continue to introduce advanced calming formulations, strengthen veterinary partnerships, and expand product accessibility to support effective anxiety management and sustained market growth.

Top Key Players

• Zoetis Inc.
• Elanco Animal Health Incorporated
• Boehringer Ingelheim International GmbH
• Merck & Co., Inc.
• Ceva Santé Animale
• Virbac
• Vetoquinol S.A.
• Dechra Pharmaceuticals PLC
• Bayer AG
• Nutramax Laboratories, Inc.
• Thorne Veterinary
• Zesty Paws, LLC
• PetHonesty

Recent Developments

• In August 2025, Zoetis raised its annual forecast following strong demand for specialty pet therapeutics. Growth was largely supported by the continued uptake of Sileo, a dexmedetomidine-based oromucosal gel, which remains the only FDA-approved treatment specifically indicated for noise-related anxiety in dogs. Increasing awareness among pet owners around behavioral health, particularly during storm and firework seasons, is expected to sustain demand for such targeted pharmaceutical solutions.
• By the end of 2025, Elanco achieved its “Big 6” innovation milestone, including the approval of Befrena, a monoclonal antibody designed for canine dermatitis management. Although primarily positioned within dermatology, Elanco is leveraging its expanded veterinary clinic engagement in 2026 to promote a broader behavioral health portfolio. This cross-portfolio strategy is expected to strengthen its innovation-driven revenue streams and enhance clinical adoption across companion animal care settings.

Report Scope